Search Results - "Battle, Mark R."

Centiloid scaling for quantification of brain amyloid with [18F]flutemetamol using multiple processing methods by Battle, Mark R., Pillay, Lovena Chedumbarum, Lowe, Val J., Knopman, David, Kemp, Bradley, Rowe, Christopher C., Doré, Vincent, Villemagne, Victor L., Buckley, Christopher J.

“…Introduction A standardised method for quantifying β-amyloid PET tracers would allow comparison across different tracers and different sites. The development…”
Get full text

Association Between Years of Education and Amyloid Burden in Patients With Subjective Cognitive Decline, MCI, and Alzheimer Disease by Hönig, Merle, Altomare, Daniele, Caprioglio, Camilla, Collij, Lyduine, Barkhof, Frederik, Van Berckel, Bart, Scheltens, Philip, Farrar, Gill, Battle, Mark R, Theis, Hendrik, Giehl, Kathrin, Bischof, Gerard N, Garibotto, Valentina, Molinuevo, José Luis L, Grau-Rivera, Oriol, Delrieu, Julien, Payoux, Pierre, Demonet, Jean Francois, Nordberg, Agneta K, Savitcheva, Irina, Walker, Zuzana, Edison, Paul, Stephens, Andrew W, Gismondi, Rossella, Jessen, Frank, Buckley, Christopher J, Gispert, Juan Domingo, Frisoni, Giovanni B, Drzezga, Alexander

“…Higher-educated patients with Alzheimer disease (AD) can harbor greater neuropathologic burden than those with less education despite similar symptom severity…”
Get full text

UTILITY OF PMOD IMAGE QUANTIFICATION SOFTWARE FOR PROCESSING [11 C]PIB AND [18 F]FLUTEMETAMOL IMAGES FOR SUVR QUANTITATION ON THE CENTILOID SCALE by Battle, Mark R, Buckley, Chris J, Smith, Adrian, Van Laere, Koen, Vandenberghe, Rik, Lowe, Val J

Get full text

IC‐P‐173: Utility of PMOD Image Quantification Software for Processing [11C]PIB and [18F]Flutemetamol Images for SUVR Quantitation on The Centiloid Scale by Battle, Mark R., Buckley, Chris J., Smith, Adrian, Van Laere, Koen, Vandenberghe, Rik, Lowe, Val J.

Get full text

The development of potential new fluorine-18 labelled radiotracers for imaging the GABAA receptor by Jackson, Alexander, Guilbert, Benedicte B., Plant, Stuart D., Goggi, Julian, Battle, Mark R., Woodcraft, John L., Gaeta, Alessandra, Jones, Clare L., Bouvet, Denis R., Jones, Paul A., O’Shea, Dennis M., Zheng, Penny Hao, Brown, Samantha L., Ewan, Amanda L., Trigg, William

“…Positron emission tomography (PET) using the tracer [11C]Flumazenil has shown changes in the distribution and expression of the GABAA receptor in a range of…”
Get full text

The development of potential new fluorine-18 labelled radiotracers for imaging the GABA(A) receptor by Jackson, Alexander, Guilbert, Benedicte B, Plant, Stuart D, Goggi, Julian, Battle, Mark R, Woodcraft, John L, Gaeta, Alessandra, Jones, Clare L, Bouvet, Denis R, Jones, Paul A, O'Shea, Dennis M, Zheng, Penny Hao, Brown, Samantha L, Ewan, Amanda L, Trigg, William

“…Positron emission tomography (PET) using the tracer [(11)C]Flumazenil has shown changes in the distribution and expression of the GABA(A) receptor in a range…”
Get full text

Novel fluorine-18 PET radiotracers based on flumazenil for GABAA imaging in the brain by Rodnick, Melissa E, Hockley, Brian G, Sherman, Phillip, Quesada, Carole, Battle, Mark R, Jackson, Alexander, Linder, Karen E, Macholl, Sven, Trigg, William J, Kilbourn, Michael R, Scott, Peter J.H

“…Abstract Introduction Two 7-fluoroimidazobenzodiazepines (AH114726 and GEH120348), analogs of flumazenil, were labeled with fluorine-18 and evaluated as…”
Get full text

Evaluation of a novel series of fluorine-18-labeled imidazobenzodiazepines as potential new positron emission tomography radioligands for the GABAA receptor by Jackson, Alexander, Battle, Mark R, O'Shea, Dennis M, Chau, Wai-Fung, Gaeta, Alessandra, Brown, Samantha L, Ewan, Amanda L, Jones, Clare L, Jones, Paul A, Woodcraft, John L, Bouvet, Denis R, Guilbert, Benedicte B, Trigg, William

“…Abstract Introduction [11 C]Flumazenil has been used to study the GABAA receptor in many preclinical and clinical studies, but the short half-life of carbon-11…”
Get full text

Improved repeatability of amyloid quantitation using FSL: Implications on ability to detect small longitudinal changes: Amyloid imaging by Msayib, Yunus, Buckley, Christopher, Battle, Mark R, Pillay, Lovena Chedumbarum

Get full text

Improved repeatability of amyloid quantitation using FSL: Implications on ability to detect small longitudinal changes by Msayib, Yunus, Buckley, Christopher, Battle, Mark R, Pillay, Lovena Chedumbarum

“…Background Monitoring changes in amyloid load requires repeatable image quantification methods. Several different brain‐image analysis pipelines are used,…”
Get full text

CSF Biomarkers and [18F]flutemetamol PET‐Derived Centiloids in Patients with SCD or MCI by Battle, Mark R, Buckley, Chris J, Farrar, Gill, Janelidze, Shorena, Palmqvist, Sebastian, Ossenkoppele, Rik, Smith, Ruben, Hansson, Oskar

“…Background CSF biomarkers are well characterised as surrogate markers for amyloid deposition and neurofibrillary tau tangles reflecting pathological features…”
Get full text

CSF Biomarkers and [18F]flutemetamol PET‐Derived Centiloids in Patients with SCD or MCI by Battle, Mark R, Buckley, Chris J, Farrar, Gill, Janelidze, Shorena, Palmqvist, Sebastian, Ossenkoppele, Rik, Smith, Ruben, Hansson, Oskar

“…Background CSF biomarkers are well characterised as surrogate markers for amyloid deposition and neurofibrillary tau tangles reflecting pathological features…”
Get full text

DETERMINING THE STABILITY OF CENTILOID VALUES FOR [18F]FLUTEMETAMOL WITHIN DIFFERENT IMAGING WINDOWS by Battle, Mark R., Buckley, Chris J., Farrar, Gillian

Get full text

DETERMINING THE STABILITY OF CENTILOID VALUES FOR [18F]FLUTEMETAMOL WITHIN DIFFERENT IMAGING WINDOWS by Battle, Mark R., Buckley, Chris J., Farrar, Gillian

Get full text

P4‐306: DETERMINING THE STABILITY OF CENTILOID VALUES FOR [18F]FLUTEMETAMOL WITHIN DIFFERENT IMAGING WINDOWS by Battle, Mark R., Buckley, Chris J., Farrar, Gillian

Get full text

IC‐P‐002: DETERMINING THE STABILITY OF CENTILOID VALUES FOR [18F]FLUTEMETAMOL WITHIN DIFFERENT IMAGING WINDOWS by Battle, Mark R., Buckley, Chris J., Farrar, Gillian

Get full text

A novel regional centiloid atlas to investigate the relationship between the quantification of [18F]flutemetamol amyloid PET and CSF Aβ42/40 in patients with SCD or MCI by Battle, Mark R, Buckley, Chris J, Farrar, Gill, Pillay, Lovena Chedumbarum, Ossenkoppele, Rik, Smith, Ruben, Hansson, Oskar

“…Background Visual assessment of [18F]flutemetamol amyloid PET images, performed regionally (frontal, lateral temporal, posterior cingulate/precuneus,…”
Get full text

DETERMINING THE UTILITY OF PMOD IMAGE QUANTIFICATION SOFTWARE FOR PROCESSING [11C]PIB AND [18F]FLUTEMETAMOL IMAGES IN A PET-ONLY PIPELINE TO GENERATE SUVR FOR QUANTIFICATION ON THE CENTILOID SCALE by Battle, Mark R., Buckley, Chris J., Smith, Adrian, Lowe, Val

Get full text

Quantification supports visual assessment of challenging amyloid‐PET images by Collij, Lyduine E., Bischof, Gerard N, Altomare, Daniele, García, David Vállez, Alves, Isadora Lopes, Battle, Mark R, Hegde, Manoj, Wolz, Robin, Gismondi, Rossella, Stephens, Andrew W., Walker, Zuzana, Scheltens, Philip, Nordberg, Agneta K, Gispert, Juan Domingo, Farrar, Gill, Drzezga, Alexander, Perissinotti, Andrés, Morbelli, Silvia, Buckley, Christopher, Garibotto, Valentina, Frisoni, Giovanni B, Barkhof, Frederik

“…Background In clinical practice, amyloid‐PET images are visually assessed to determine the presence or absence of amyloid pathology. The expected arrival of…”
Get full text

Inverse relationship between education and amyloid burden in individuals with subjective cognitive decline plus and mild cognitive impairment by Hönig, Merle C., Caprioglio, Camilla, Collij, Lyduine E., Frisoni, Giovanni B, Barkhof, Frederik, Farrar, Gill, Scheltens, Philip, Delrieu, Julien, Molinuevo, Jose Luis, Grau‐Rivera, Oriol, Walker, Zuzana, Nordberg, Agneta K, Demonet, Jean‐François, Stephens, Andrew W., Battle, Mark R, Buckley, Christopher, Gispert, Juan Domingo, Jessen, Frank, Altomare, Daniele, Drzezga, Alexander

“…Background Higher educated patients with MCI can tolerate more neuropathology than lower educated patients with similar clinical impairment. It is not known…”
Get full text